Erratum: Dual Modifications of α-Galactosylceramide Synergize to Promote Activation of Human Invariant Natural Killer T Cells and Stimulate Anti-tumor Immunity (Cell Chemical Biology (2018) 25(5) (571–584.e8) (S2451945618300734) (10.1016/j.chembiol.2018.02.009))

Divya Chennamadhavuni, Noemi Alejandra Saavedra-Avila, Leandro J. Carreño, Matthew J. Guberman-Pfeffer, Pooja Arora, Tang Yongqing, Rhys Pryce, Hui Fern Koay, Dale I. Godfrey, Santosh Keshipeddy, Stewart K. Richardson, Srinivasan Sundararaj, Jae Ho Lo, Xiangshu Wen, José A. Gascón, Weiming Yuan, Jamie Rossjohn, Jérôme Le Nours, Steven A. Porcelli, Amy R. Howell

Microbiology & Immunology

Research output: Contribution to journal › Comment/debate › peer-review

3 Scopus citations

Fingerprint

Dive into the research topics of 'Erratum: Dual Modifications of α-Galactosylceramide Synergize to Promote Activation of Human Invariant Natural Killer T Cells and Stimulate Anti-tumor Immunity (Cell Chemical Biology (2018) 25(5) (571–584.e8) (S2451945618300734) (10.1016/j.chembiol.2018.02.009))'. Together they form a unique fingerprint.

Erratum: Dual Modifications of α-Galactosylceramide Synergize to Promote Activation of Human Invariant Natural Killer T Cells and Stimulate Anti-tumor Immunity (Cell Chemical Biology (2018) 25(5) (571–584.e8) (S2451945618300734) (10.1016/j.chembiol.2018.02.009))

Fingerprint

Medicine & Life Sciences

Chemical Compounds